Health, biotech and life-sciences are being reshaped by AI/ML, data platforms, digital-health, regulatory change and ESG (access, sustainability in pharma/med-tech).
Our services: digital-health strategy/adoption, regulatory & audit assurance for life-sciences, AI in drug-development/analytics, tax incentives for R&D, sustainability in pharma/med-tech supply-chains, risk/cyber advisory for patient data and biotech IP.
Healthcare in the GCC is expanding rapidly due to population growth, medical tourism, and government investments in digital health, telemedicine, and hospital infrastructure.
Pharmaceuticals, biotechnology, and medical device companies in the region are scaling fast through R&D investments, localized manufacturing, and regulatory enhancements.
Education systems across the GCC are adopting modern learning platforms, digital classrooms, and private sector partnerships. With rising demand for quality institutions, the sector continues to expand.